Diary - News
All news MaaT Pharma selected for the next Big Booster
MaaT Pharma, which develops the first treatment using an autologous intestinal microbiota transplant, has successfully reached second milestone of Big Booster, the first international non-profit acceleration program organized jointly by Boston (USA) and Lyon (France). After a 3-day boot camp in Lyon, on October 27-29, MaaT Pharma has been selected among 72 participants to be featured in the top-20 European start-ups that will participate to a second boot camp in Boston in February 2016.
By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree